Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

40 results about "Feeder Layer" patented technology

A layer of supportive cells that are irradiated to prevent replication but can still secrete growth enhancing factors for use in co-culture

Method for induced differentiation of skeletal muscle cells by porcine embryonic stem cells

The invention relates to a method for induced differentiation of skeletal muscle cells by porcine embryonic stem cells. Comprising the following steps: (1) constructing a PAX7-overexpressed porcine embryonic stem cell stable cell line; (2) induced differentiation of skeletal muscle cells; (3) performing immunofluorescence identification; wherein the step (1) specifically comprises the following steps: 1.1, constructing a DOX (deoxyribonucleic acid) induced PAX7 expression plasmid PiggyBac-TRE3G-EF1a-PAX7; 1.2, performing electrical transformation on the porcine embryonic stem cells cultured for two days, and adding Buffer E into an electrical transformation cup; taking Buffer R, mixing plasmid and PBase, uniformly mixing, and re-suspending cell precipitate; 1.3, after electrotransformation is finished, the cells are planted on the feeding layer, Y-27632 is added into the culture medium, and the culture medium without Y-27632 is replaced with the culture medium without Y-27632 on the second day; and 1.4, after culturing for 3-4 days, selecting the porcine embryonic stem cells which are successfully subjected to electrotransfection for amplification culture, and naming PAX7-PESCs.
Owner:BEIJING SINOGENE BIOTECHNOLOGY CO LTD

Method for expansion and maintenance of NK cells for immunotherapy

The present invention discloses a method for expansion of natural killer (NK) cells or CAR-NK cells using peripheral blood mononuclear cells (PBMCs) and culturing the cells in a medium comprising a feeder layer having a population of mesenchymal stem cells (MSCs) with disrupted or deleted MHC class I gene and / or MHC class II gene and a heterologous gene for expressing Interleukin-21 (IL-21), and Interleukin-2 (IL-2). The present disclosure further provides a method and a model for evaluating natural killer (NK) cells or CAR-NK cells using tester line comprising induced Pluripotent stem cells (iPSCs) comprising disrupted or deleted MHC class I gene and / or MHC class II gene and a heterologous gene encoding a tumor antigen.
Owner:NKURE THERAPEUTICS PTE LTD

Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs

The invention provides cell culture conditions for culturing stem cells, including feeder-free conditions for generating and culturing human induced pluripotent stem cells (iPSCs). More particularly, the invention provides a culture platform that allows long-term culture of pluripotent cells in a feeder-free environment; reprogramming of cells in a feeder-free environment; single-cell dissociation of pluripotent cells; cell sorting of pluripotent cells; maintenance of an undifferentiated status; improved efficiency of reprogramming; and generation of a naïve pluripotent cell.
Owner:FATE THERAPEUTICS INC

Method for culturing primary spermatogonial stem cells of Tibetan sheep

The invention provides a method for culturing primary spermatogonial stem cells of Tibetan sheep, and belongs to the technical field of cell separation and culture. The culture method provided by the invention comprises the following steps: disinfecting and cleaning testis tissues of Tibetan sheep lambs; shearing tissue blocks, and digesting and cleaning to obtain a single-cell suspension of the seminiferous tubule; purifying the single-cell suspension, and culturing without a feeding layer or with the feeding layer; the culture without the feeding layer refers to culture in a laminin-coated culture container by using a feeding-layer-free MEM alpha culture medium or a StemProTM-34SFM complete culture medium; culture with a feeding layer refers to culture in a mouse fibroblast line feeding layer or a Tibetan sheep primary testicular sertoli feeding layer, and a feeding layer MEMS alpha culture medium is added. According to the culture method provided by the invention, the Tibetan sheep spermatogonial stem cells with higher purity can be obtained through separation, the subsequent proliferation of the spermatogonial stem cells can be remarkably promoted, and the apoptosis of the spermatogonial stem cells can be inhibited.
Owner:LANZHOU INST OF ANIMAL SCI & VETERINARY PHARMA OF CAAS

Chemically defined airway basal stem cell culture medium

PCT designated stageWO2026012293A1Unknown materialsArtificial cell constructsMatrigelFeeder Layer
Disclosed is a chemically defined airway basal stem cell culture medium. The provided culture medium involves a simple preparation method and high safety, and does not require a feeder layer or a matrigel-coated culture plate. By means of the culture medium, primary cultured airway basal stem cells achieve good stability; and after multiple passages, the normal morphology of the basal stem cells can be maintained and good differentiation potential can be maintained. In addition, the culture medium has clear components, and can meet both scientific research-grade and clinical-grade applications of airway basal stem cells.
Owner:GUANGZHOU NAT LAB

Tibetan sheep primary spermatogonial stem cell separation, purification and culture method and application thereof

The invention relates to the technical field of spermatogonial stem cell separation, in particular to a Tibetan sheep primary spermatogonial stem cell separation, purification and culture method and application thereof. The method comprises the following steps: (1) treating testicular tissues of Tibetan sheep by using mixed enzyme liquid and enzymatic hydrolysate in sequence to obtain single-cell suspension of seminiferous tubules; (2) purifying the single-cell suspension of the seminiferous tubules obtained in the step (1) by using a differential adhesion method to obtain spermatogonial stem cells; and (3) inoculating the spermatogonial stem cells obtained in the step (2) into a feeding layer for culture. The method is simple and easy to implement, the primary spermatogonial stem cells of the Tibetan sheep can be obtained through effective separation and purification, and the purity of the spermatogonial stem cells is high.
Owner:LANZHOU INST OF ANIMAL SCI & VETERINARY PHARMA OF CAAS

Mononuclear cell derived NK cells

Cord blood or peripheral blood NK cells are prepared from whole blood mononuclear cells without the need to isolate CD34+ hematopoietic stem cells or NK cells, and without the need for a feeder layer. Advantageously, the methods presented herein use an enrichment process that uses antiCD16 agonist antibodies, antiCD3 antibodies, and N-803. Moreover, contemplated processes are suitable for adaptation into a fully automated production process (GMP in a box).
Owner:IMMUNITYBIO INC

Feed-layer-free and serum-free bovine embryonic stem cell culture medium, culture system and culture method

The invention belongs to the technical field of cell biology, and particularly relates to a feeder-layer-free and serum-free bovine embryonic stem cell culture medium, a culture system and a culture method. The bovine embryonic stem cell culture medium comprises a conditioned culture medium and additives, the additives are IWR-1 and activin A, and the concentrations of the IWR-1 and the activin A in the conditioned culture medium are 2.5-5 [mu] M and 20-25 ng / mL respectively; the culture system comprises a bovine embryonic stem cell culture medium, gelatin with the mass concentration of 0.1-0.2% and a subculture medium, and the gelatin with the mass concentration of 0.1-0.2% is used for providing an attachment matrix for bovine embryonic stem cells; the subculture medium is prepared by adding Y27632 into a bovine embryonic stem cell culture medium. The cost of the extracellular matrix is reduced, and the feeder-layer-free bovine embryonic stem cell has high single cell passage efficiency and is convenient for gene editing operation.
Owner:NORTHWEST A & F UNIV

Method for repairing spinal cord injury by inducing spinal cord GABAergic neural precursor cells through human pluripotent stem cells and application

The invention provides a method for producing functional spinal cord GABAergic neural precursor cells from human pluripotent stem cells, which successfully realizes directional differentiation of the human pluripotent stem cells by adopting a feeder-layer-free culture method based on a three-stage in-vitro induced differentiation strategy. The invention further provides application of the cells obtained through the method in treatment of spinal cord injury, a novel strategy based on the functional spinal cord GABAergic neural precursor cells is provided, a new thought and means are provided for treatment of spinal cord injury, and stem cell treatment is expected to proceed towards clinical precision and industrial application.
Owner:WUHAN HONGCHEN INNOVATION BIOTECHNOLOGY CO LTD

Methods for inducing differentiation from pluripotent stem cells to ectodermal cells and methods for making such cells

To provide methods for inducing differentiation to ectodermal cells excellent in differentiation-inducing efficiency from pluripotent stem cells to ectodermal cells and excellent in culture operability as well as methods for making such cells.SOLUTION: Methods for inducing differentiation from pluripotent stem cells to ectodermal cells comprise the steps of: (1) coating a cell culture substrate with one or more substances selected from the group consisting of Matrigel, laminin, fibronectin, vitronectin and collagen where the substrate comprises a region having cell adhesiveness and cell-proliferating property and a region having neither of them and then seeding pluripotent stem cell 1; (2) conducting adhesion culture of the seeded pluripotent cells in the presence of an undifferentiation-maintaining medium in feeder-free conditions to form agglutination of pluripotent stem cells 2 adhered to the cell culture substrate; (3) culturing the formed agglutination of pluripotent stem cells in the presence of a culture medium containing a differentiation-inducing agent so that the cells adhered to the cell culture substrate form germ layer 3; and (4) culturing the formed germ layer in the presence of a culture medium containing the differentiation-inducing agent in the adhered state to the cell culture substrate to form ectodermal cell aggregates 4.SELECTED DRAWING: Figure 1
Owner:TOSOH CORP

Methods of making nk cells, nk cells, and uses thereof

PendingCN122128232ANervous disorderBlood/immune system cellsCD16Aβ oligomers
This invention discloses a method for preparing NK cells, the NK cells obtained thereby, and their applications. The method includes: sorting NK cells from peripheral blood of an allogeneic donor; culturing them in a serum-free medium containing CD3 monoclonal antibody, CD16 antibody, and IL-2, without the need for a feeder layer; preferably, IL-21 is added for amplification on days 3-5 of culture, and the cells are cultured for 20-40 days. This method yields non-genetically modified NK cells, among which CD56... bright The NK cells comprise >90% of the cell line and highly express a variety of activating and functional molecules. These NK cells effectively clear Aβ oligomers and senescent cells, and alleviate neuroinflammation. In treatment, intracranial injection achieves equivalent or better efficacy with only about 1 / 10th the dose administered intravenously, significantly clearing Aβ deposits in the brains of AD model mice and improving pathology.
Owner:SHANGHAI NK CELLTECH CO LTD

Cell culture platform for single cell sorting and enhanced iPSC reprogramming

The present invention provides cell culture conditions for culturing stem cells, including feeder-free conditions for producing and culturing human induced pluripotent stem cells (iPSCs). More specifically, the present invention provides a culture platform that allows long-term culture of pluripotent cells in a feeder-free environment; reprogramming of cells in a feeder-free environment; single cell dissociation of pluripotent cells; cell sorting of pluripotent cells; maintenance of an undifferentiated state; increased efficiency of reprogramming; and the generation of original pluripotent cells.
Owner:FATE THERAPEUTICS INC

Complete feeder-free long-term culture system of bovine embryonic stem cells and its application

PendingCN122278752ABiotechnologyFeeder Layer
This invention relates to the field of bovine embryonic stem cell culture technology, and particularly to a long-term culture system for morphological bovine embryonic stem cells completely without a feeder layer and its applications. After trying various culture methods, this invention establishes a feeder-free bovine morphological embryonic stem cell line (FF-bESCs). Bovine morphological embryonic stem cells cultured under the feeder-free conditions provided by this invention can maintain stable proliferation capacity and pluripotency over a long period. The bovine morphological embryonic stem cells provided by this invention can undergo gene editing and can be effectively induced to differentiate into primordial germ cell-like cells (PGCLCs). This invention lays an important foundation for the standardized and large-scale culture of bovine embryonic stem cells under feeder-free conditions, and for their application in stem cell breeding and other fields.
Owner:CHINA AGRI UNIV

Feeder-free, serum-free bovine embryonic stem cell culture medium, culture system and culture method

The application belongs to the technical field of cell biology, and particularly relates to a feeder-free and serum-free bovine embryonic stem cell culture medium, a culture system and a culture method. The bovine embryonic stem cell culture medium comprises a conditioned medium and an additive. The additive is IWR-1 and activin A. The concentrations of IWR-1 and activin A in the conditioned medium are 2.5-5 muM and 20 ng / mL-25 ng / mL respectively. The culture system comprises the bovine embryonic stem cell culture medium, 0.1%-0.2% gelatin in mass concentration and a subculture medium. The 0.1%-0.2% gelatin in mass concentration is used to provide an attachment matrix for the bovine embryonic stem cell. The subculture medium is prepared by adding Y27632 to the bovine embryonic stem cell culture medium. The application reduces the cost of extracellular matrix, and the feeder-free bovine embryonic stem cell has high single cell subculture efficiency and is convenient for gene editing operation.
Owner:NORTHWEST A & F UNIV

Human airway basal stem cell culture medium with definite chemical components

The invention discloses a human airway basal stem cell culture medium as well as a preparation method and application thereof. The culture medium provided by the invention is simple in preparation method and high in safety, a culture plate does not need to be coated with a feeding layer or matrigel, and the airway basal stem cells subjected to primary culture are good in stability; after multiple passage, the normal form of the basal stem cells can be maintained, and good differentiation potential can be maintained; meanwhile, components of the culture medium are clear, and scientific research-grade and clinical-grade application of the airway basal stem cells can be met at the same time.
Owner:GUANGZHOU NAT LAB

Feeder-based and feeder-free stem cell culture systems for stratified epithelial stem cells and methods of use related thereto

To provide a defined culture medium for isolating stratified epithelial stem cells and stably maintaining the epigenetics of the stratified epithelial stem cells during multiple passages, and to provide clonal stratified epithelial stem cells isolated using the defined culture medium.SOLUTION: And a defined culture medium comprising each of ROCK (Rho kinase) inhibitors, mitogenic growth factors, insulin or IGF, TrkA inhibitors, and Oct4 activators, and comprising at least one of VEGF inhibitors, tyrosine kinase inhibitors, and / or FGF10 or FGF10 agonists, and optionally further comprising TGF β signaling pathway inhibitors and / or bone morphogenetic proteins (BMP) antagonists, wherein the defined culture medium supports epigenetically stable growth and proliferation of stem cells of stratified epithelial tissue origin in culture.SELECTED DRAWING: Figure 1
Owner:UNIV HOUSTON SYST

Keratin 15 type hair follicle stem cell culture medium, adherent culture method and application

The invention provides a keratin 15 type hair follicle stem cell culture medium, an adherent culture method and application, and belongs to the technical field of stem cell culture. The invention provides a keratin 15 type hair follicle stem cell culture medium, which comprises a basic culture medium, a serum substitute and a nutrition additive, a mixed culture medium containing a DMEM basic culture medium and an F12 basic culture medium is used as the basic culture medium, and an epidermal growth factor, a platelet lysate and a bovine pituitary extract are used as the serum substitute. The keratin 15 type hair follicle stem cells are cultured on the basis of the culture medium, proliferation-terminated autologous mesenchymal cells serve as a feeding layer, the activity of the hair follicle stem cells p63 can be reserved, and the keratin 15 positive hair follicle stem cells are amplified.
Owner:HANGZHOU AISIJIA BIOTECHNOLOGY CO LTD

Compositions and methods for induced stem cell differentiation to oligodendrocytes

PCT designated stageWO2026112110A1Nervous system cellsNucleic acid vectorOLIG2Feeder Layer
A method of differentiating nonhuman primate induced pluripotent stem cells (iPSCs) to oligodendrocytes is provided. The method may include providing a modified vector comprising a piggyBac vector backbone that expresses one or more differentiation factor genes, including SOX10, OLIG2, and NKX6-2. The piggyBac vector backbone may comprise one or more terminal inverted repeats and one or more transposase recognition sites configured to interact with a piggyBac transposase to mediate genomic integration at TTAA or noncanonical target sequences. The vector may further include a selectable marker and a promoter for regulated expression. The modified vector may be introduced into nonhuman primate iPSCs, for example from Macaca fascicularis, by electroporation and used in a feeder-free differentiation workflow. The resulting differentiated cells may be identified by expression of oligodendrocyte-associated markers including O4, O1, PDGFRA, MOG, GALC, CNPase, and myelin basic protein (MBP).
Owner:EXIR LLC

Methods and applications of mammalian retinal stem cell production

The invention provides an in vitro method for producing an isolated mammalian primitive retina stem cell (pRSC), comprising: (a) culturing an isolated embryonic stem cell (ESC) from a mammal in a cell culture medium that is free of feeder cells, feeder layer conditioned medium, or serum to produce and grow a culture of the isolated ESC; and (b) contacting the culture of the isolated ESC so grown with one or more of a Wnt or TGF-beta / BMP signaling inhibitor to differentiate the isolated ESC of (a) into a primitive retina stem cell, thereby producing an isolated mammalian pRSC.
Owner:RGT UNIV OF CALIFORNIA

Method for inducing efficient amplification of NK (Natural Killer) cells through synergistic effect of exosome and immunosuppressant

The invention provides a method for inducing efficient amplification of NK cells through the synergistic effect of exosome and immunosuppressor, and belongs to the technical field of cell culture, and the method comprises the following steps: 1) extracting and purifying stem cell exosome; the stem cells are human umbilical cord mesenchymal stem cells; 2) separating CBMC cells and plasma from the umbilical cord blood, inactivating the plasma, activating platelets, incubating and separating to obtain super plasma; 3, CBMC cells are inoculated and cultured in a low-oxygen incubator for 10-16 h, then the exosomes in the step 1 are added, culture continues to be conducted for 10-16 h, the CBMC cells are transferred to a normal oxygen environment, culture does not exceed 4 h, a culture medium and super plasma are supplemented, culture continues to be conducted, and amplified NK cells are obtained.According to the technical scheme, in-vitro culture of the high-activity NK cells can be efficiently amplified and maintained without a feeding layer is achieved.
Owner:SICHUAN XIANGXUE CELL BIOTECHNOLOGY CO LTD

Stem cell culture systems for columnar epithelial stem cells, and uses related thereto

The present invention relates to a culture media system that useful for the isolation and epigenetically stable propagation of normal stem cells in culture which are derived from columnar epithelial tissues and cancer stem cells from epithelial cancers. In certain embodiments, the culture system is a feeder-free system.
Owner:UNIV HOUSTON SYST

Application of tetracycline drugs in synchronous separation and maintenance of bovine embryonic stem cells and bovine trophoblast stem cells

The invention discloses application of tetracycline drugs in synchronous separation and maintenance of bovine embryonic stem cells and bovine trophoblast stem cells. Belongs to the technical field of cytobiology and animal embryo engineering. According to the method, cattle blastocysts or cell clusters in the cattle blastocysts are cultured in a culture medium containing tetracycline drugs, so that the dryness of bESCs and bTSCs is synchronously separated and maintained in the same culture system. The technical problem of synchronous separation of bESCs and bTSCs is solved by utilizing the bidirectional regulation and control capability of tetracycline drugs for the first time, and an efficient and low-cost standardized platform is provided for artificial embryos, regenerative medicine and agricultural bioengineering.
Owner:NORTHWEST A & F UNIV

Mrna-LNP-based reprogramming method for induced pluripotent stem cells

An mRNA-LNP-based reprogramming method for induced pluripotent stem cells. Specifically, a cationic lipid is used to encapsulate an mRNA mixture of a plurality of reprogramming factors to prepare a nano-liposome containing the reprogramming factors; a certain amount of the nano-liposome containing the reprogramming factors is dropwise added into adult cells in a feeder-free system to obtain reprogrammed induced pluripotent stem cells, thereby achieving a low-cost, low-toxicity, efficient, stable, repeatable, and safer iPSCs reprogramming technology.
Owner:UBRIGENE (MA) BIOSCIENCES INC